Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

49.02
Delayed Data
As of 4:02pm ET
 +1.23 / +2.57%
Today’s Change
40.67
Today|||52-Week Range
68.00
+5.90%
Year-to-Date
What Exactly Did Allergan and Teva Sell to Impax?
Jun 21 / TheStreet.com - Paid Partner Content
3 High-Growth Stocks You Don't Need to Babysit
Jun 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close47.79
Today’s open48.45
Day’s range48.27 - 49.03
Volume483,556
Average volume (3 months)320,291
Market cap$8.2B
Dividend yield0.64%
Data as of 4:02pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.14%
Revenue growth (last year)-2.51%
P/E ratio0.3
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+4.46+3.36%
IDXXIDEXX Laboratories I...+1.91+2.21%
MDVNMedivation Inc+1.18+2.08%
VRXValeant Pharmaceutic...+1.27+6.78%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.47
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts

Partner Offers

Search for Jobs